He sees the report as hurting Baidu's reputation, but doesn't think it will be hurt financially as much as Monday's share price decline seemed to indicate. Lee doesn't think health-related ads make up that much of the company's total advertising.
My gut tells me that they'll keep this one down all the way to the close. Then after hour it'll trade up awaiting BIDU's reply.
I do believe the call/put ratio heavily favored the call so this is an interesting move today.
Tomorrow, the gap will largely be closed and the news will read "BIDU made a mistake and will fix it." Oversold condition with short covering. Analysts will likely downgrade and keep price target around $200-$300. This gives them an out...i.e. using silly negative press to cover their behind.
BIDU has been steadily declining since $320...so we're almost 60% down on a growth stock in China. Go figure.
If the company press release is lame, it could fall more tomorrow, although not much more from here.